Health-related quality of life in the ENDEAVOR study : carfilzomib-dexamethasone vs bortezomib-dexamethasone in relapsed/refractory multiple myeloma

Ludwig, Heinz; Moreau, Philippe; Dimopoulos, Meletios A.; Mateos, Maria-Victoria; Kaiser, Martin; Hajek, Roman; Feng, Shibao; Cocks, Kim; Buchanan, Jaqueline; Weisel, Katja

dc.contributor.author	Weisel, Katja
dc.date.accessioned	2020-06-09T08:23:44Z
dc.date.available	2020-06-09T08:23:44Z
dc.date.issued	2019
dc.identifier.issn	2044-5385
dc.identifier.uri	http://hdl.handle.net/10900/101381
dc.language.iso	en	de_DE
dc.publisher	Nature Publishing Group	de_DE
dc.relation.uri	http://dx.doi.org/10.1038/s41408-019-0181-0	de_DE
dc.subject.ddc	610	de_DE
dc.title	Health-related quality of life in the ENDEAVOR study : carfilzomib-dexamethasone vs bortezomib-dexamethasone in relapsed/refractory multiple myeloma	de_DE
dc.type	Article	de_DE
utue.quellen.id	20190926111821_02521
utue.personen.roh	Ludwig, Heinz
utue.personen.roh	Moreau, Philippe
utue.personen.roh	Dimopoulos, Meletios A.
utue.personen.roh	Mateos, Maria-Victoria
utue.personen.roh	Kaiser, Martin
utue.personen.roh	Hajek, Roman
utue.personen.roh	Feng, Shibao
utue.personen.roh	Cocks, Kim
utue.personen.roh	Buchanan, Jaqueline
utue.personen.roh	Weisel, Katja
dcterms.isPartOf.ZSTitelID	Blood Cancer Journal	de_DE
dcterms.isPartOf.ZS-Issue	Article 23	de_DE
dcterms.isPartOf.ZS-Volume	9	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE